MediciNova, Inc., (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), announced that an abstract regarding MediciNova’s ongoing clinical trial of MN-166 (ibudilast) in ALS (amyotrophic lateral sclerosis) has been accepted for dual presentation at the American Academy of Neurology (AAN) 68th Annual Meeting to be held April 15-21, 2016, at the Vancouver Convention Centre in Vancouver, BC, Canada.
MediciNova Inc. (NASDAQ:MNOV) belongs to Healthcare sector. Its weekly performance is 29.75%. On last trading day company shares ended up at $5.80.
Comstock Holding Companies, Inc. (NASDAQ:CHCI) shares decreased -5.75% in last trading session and ended the day at $1.64. CHCI Gross Margin is 15.80% and its return on assets is -10.60%. Comstock Holding Companies, Inc. (NASDAQ:CHCI) quarterly performance is -21.49%.
ServiceNow (NYSE:NOW), the enterprise cloud company, today announced it’s extending its industry-leading automation and orchestration expertise to transform the way organizations respond to threats. ServiceNow’s first offering, Security Operations, gives both security and IT teams a single platform to respond to security incidents and vulnerabilities.
On 24 February, ServiceNow, Inc. (NYSE:NOW) shares decreased -0.87% and was closed at $52.55. ServiceNow, Inc. (NYSE:NOW) year to date (YTD) performance is -39.29%.
On 10 February, Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) reported Total revenues for the fourth quarter of 2015 were $21.2 million, compared with $23.0 million for the same period in 2014. Royalty and milestone revenues were higher compared with the same period in the prior year, and Captisol® material sales were lower based on timing of supply purchases. Royalty revenues were $11.5 million, compared with $9.4 million for the same period in 2014 primarily due to higher royalties from Promactaand Kyprolis.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) ended the last trading day at $92.36. Company weekly volatility is calculated as 4.14% and price to cash ratio as 9.19. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) showed a weekly performance of 2.21%.
On 9 February, Aware, Inc. (NASDAQ:AWRE) reported Revenue decreased by $4.1 million in 2015 primarily as a result of $5.8 million lower hardware and services revenue from two U.S. government military customers. Lower sales from these customers were partially offset by $1.7 million of higher net revenue from other sources. Two contributing factors behind higher net revenue from other sources were sales to commercial customers and the medical imaging software license sale mentioned earlier.
Aware, Inc. (NASDAQ:AWRE) shares increased 5.20% in last trading session and ended the day at $3.64. AWRE Gross Margin is 87.20% and its return on assets is 7.80%. Aware, Inc. (NASDAQ:AWRE) quarterly performance is 18.95%.